Smarter Decisions,
Better Care
UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point of care decisions.
For more information, click below.
Subscribers log in here
Related articles
| AuthorsGary C Curhan, MD, ScDMichael A Becker, MD | Section EditorStanley Goldfarb, MD | Deputy EditorJohn P Forman, MD, MSc |
Topic Outline
INTRODUCTION
There are three different types of renal disease induced by uric acid or urate crystal deposition: acute uric acid nephropathy, chronic urate nephropathy, and uric acid nephrolithiasis [1]. The first two disorders will be reviewed here, while uric acid nephrolithiasis is discussed separately. (See "Uric acid nephrolithiasis".)
ACUTE URIC ACID NEPHROPATHY
Acute uric acid nephropathy (UAN) is characterized by acute oliguric or anuric renal failure due to uric acid precipitation within the tubules [1,2]. This is most often due to overproduction and overexcretion of uric acid in patients with lymphoma, leukemia, or a myeloproliferative disease (such as polycythemia vera), particularly after chemotherapy or radiation has induced rapid cell lysis. (See "Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors" and "Overview of the complications of acute myeloid leukemia".)
Less frequent causes of UAN include tissue catabolism due to seizures or treatment of solid tumors, primary overproduction of uric acid due to the rare syndrome of severe hypoxanthine-guanine phosphoribosyltransferase deficiency (Lesch-Nyhan syndrome), or hyperuricosuria due to decreased uric acid reabsorption in the proximal tubule, as can occur with a Fanconi-like syndrome [1-4] or with exercise in patients with familial renal hypouricemia due to an inherited deficiency in the activity of the urate-anion transporter URAT1. (See "Hyperkinetic movement disorders in children", section on 'Lesch-Nyhan syndrome' and "Hypouricemia: Causes and clinical significance", section on 'Familial renal hypouricemia' and "Hypouricemia: Causes and clinical significance", section on 'Acute kidney injury'.)
Clinical manifestations — UAN is typically associated with no symptoms referable to the urinary tract, although flank pain can occur if there is renal pelvic or ureteral obstruction. The diagnosis should be suspected when acute kidney injury develops in any of the above settings in association with marked hyperuricemia (plasma uric acid concentration generally above 15 mg/dL or 893 µmol/L). This is in contrast to most other forms of acute kidney injury in which the plasma uric acid concentration usually is less than 12 mg/dL (714 µmol/L), except for prerenal disease in which there is an increase in proximal sodium and urate reabsorption.
The urinalysis in UAN may show many uric acid crystals (picture 1A-B), but can be relatively normal due to no output from the obstructed nephrons. Overexcretion of uric acid can be documented in many patients by a uric acid-to-creatinine ratio (mg/mg) above 1.0 on a random urine specimen; in comparison, the value is below 0.60 to 0.75 in most other forms of acute kidney injury [5].
Subscribers log in here